These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3300952)

  • 21. Idarubicin in blastic crisis of chronic myelogenous leukemia.
    Lambertenghi-Deliliers G; Annaloro C; Cortellaro M; Pozzoli E; Oriani A; Polli EE
    Haematologica; 1991; 76(5):406-8. PubMed ID: 1806446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relapse of chronic myeloid leukemia (CML) in lymphoid crisis after allogeneic bone marrow transplantation for CML in chronic phase with busulfan plus cyclophosphamide regimen.
    Takami A; Chuhjo T; Nakao S
    Haematologica; 2002 Jun; 87(6):659-61. PubMed ID: 12031925
    [No Abstract]   [Full Text] [Related]  

  • 23. Prolonged survival (17 years) in a patient with chronic myelogenous leukemia after therapy for Hodgkin's disease.
    Salvagno L; Sorarú M; Leszl A; Koussis H; De Franchis G; Fiorentino MV
    Leuk Lymphoma; 1994 Dec; 16(1-2):177-81. PubMed ID: 7696925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two consecutive spontaneous regressions to chronic phase in a patient with blastic transformation of chronic myelogenous leukemia.
    Cağirgan S; Sencan M; Tombuloglu M; Ozdemir E; Hekimgil M; Büyükkeçeci F
    Leuk Lymphoma; 1998 Apr; 29(3-4):423-5. PubMed ID: 9684940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful treatment of accelerated and blastic phase of chronic myeloid leukemia with high-dose interferon-alpha combined with hydroxyurea.
    Jehn U; Heinemann V
    Cancer Detect Prev; 1998; 22(3):258-64. PubMed ID: 9618049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homoharringtonine combined with cytarabine to treat chronic myelogenous leukemia in myeloid blast crisis and its impact on bone marrow CD34+CD7+ cells.
    Li Y; Deng Z; Zho J; Ding B; Shi Y; Li Y
    Acta Haematol; 2014; 132(2):172-6. PubMed ID: 24603361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Granulocytic sarcoma presented as a reactivation of chronic myeloid leukemia after allogenic marrow transplantation.
    de Oliveira JS; Chauffaille Mde L; Colleoni GW; Morelli VM; Hauache OM; Alberti VN; Kerbauy J
    Sao Paulo Med J; 1998; 116(2):1689-91. PubMed ID: 9778890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allogeneic bone marrow transplantation in the treatment of hematologic diseases.
    Yee GC; McGuire TR
    Clin Pharm; 1985; 4(2):149-60. PubMed ID: 3886273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of chronic granulocytic leukemia in blastic crisis.
    Canellos GP
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():131-2. PubMed ID: 2565744
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of blast crisis of chronic myeloid leukemia].
    Kotlarek-Haus S
    Acta Haematol Pol; 1992; 23(2 Suppl 1):23-9. PubMed ID: 1488869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphoid blast crisis of chronic myelogenous leukemia occurring more than 11 years after receiving an allogeneic bone marrow transplant for chronic myelogenous leukemia in myeloid blast crisis at onset.
    Fukuno K; Tsurumi H; Yamada T; Oyama M; Matsuyama T; Terakura S; Kodera Y; Moriwaki H
    Bone Marrow Transplant; 2003 Feb; 31(3):211-3. PubMed ID: 12621483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Successful allogeneic bone marrow transplantation following fungal liver abscess treatment in a patient with chronic myeloid leukemia in blastic crisis].
    Takahashi N; Maruta A; Hashimoto C; Kato K; Tanabe J; Kodama F; Oba R; Harada H; Omine M
    Rinsho Ketsueki; 2000 Dec; 41(12):1247-53. PubMed ID: 11201149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allogeneic bone marrow transplantation from an unrelated donor for the treatment of chronic myelogenous leukemia in blast crisis in a patient with Kleinfelter's syndrome.
    Toubai T; Tanaka J; Ota S; Miura Y; Toyoshima N; Asaka M; Imamura M
    Leuk Lymphoma; 2004 Apr; 45(4):829-31. PubMed ID: 15160966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid onset of chronic granulocytic leukaemia after treatment for Hodgkin's disease.
    Jackson GH; Latham JA; Lennard AL; Taylor PR; Proctor SJ
    Br J Haematol; 1994 May; 87(1):193-5. PubMed ID: 7947245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allogeneic marrow transplantation for refractory Hodgkin's disease.
    Phillips GL; Reece DE; Barnett MJ; Connors JM; Fay JW; Herzig GP; Herzig RH; Klingemann HG; Shepherd JD; Wolff SN
    J Clin Oncol; 1989 Aug; 7(8):1039-45. PubMed ID: 2474058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current therapeutic strategies in Hodgkin's disease.
    Canellos GP
    Ann Oncol; 1992 Sep; 3 Suppl 4():67-8. PubMed ID: 1450082
    [No Abstract]   [Full Text] [Related]  

  • 37. Successful treatment of extramedullary blast crisis of chronic myelogenous leukemia with imatinib mesylate (STI571).
    Naito K; Mori T; Miyazaki K; Tsukada Y; Ikeda Y; Okamoto S
    Intern Med; 2003 Aug; 42(8):740-2. PubMed ID: 12924504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).
    Michel G; Leverger G; Leblanc T; Nelken B; Baruchel A; Landman-Parker J; Thuret I; Bergeron C; Bordigoni P; Esperou-Bourdeau H; Perel Y; Vannier JP; Schaison G
    Bone Marrow Transplant; 1996 Feb; 17(2):191-6. PubMed ID: 8640165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterisation of blast cells during blastic phase of chronic myeloid leukaemia by immunophenotyping--experience in 60 patients.
    Saikia T; Advani S; Dasgupta A; Ramakrishnan G; Nair C; Gladstone B; Kumar MS; Badrinath Y; Dhond S
    Leuk Res; 1988; 12(6):499-506. PubMed ID: 3165486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups.
    Zittoun RA; Mandelli F; Willemze R; de Witte T; Labar B; Resegotti L; Leoni F; Damasio E; Visani G; Papa G
    N Engl J Med; 1995 Jan; 332(4):217-23. PubMed ID: 7808487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.